Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax
Sign Up to like & getrecommendations! Published in 2019 at "mSphere"
DOI: 10.1128/msphere.00282-19
Abstract: Inhalational anthrax caused by Bacillus anthracis, a spore-forming Gram-positive bacterium, is a highly lethal infection. Antibodies targeting the protective antigen (PA) binding component of the toxins have recently been authorized as an adjunct to antibiotics,… read more here.
Keywords: questionable efficacy; antibodies treatment; efficacy therapeutic; inhalational anthrax ... See more keywords